Share this post on:

d glycation end-products. Basically, glycation is a condensation of free carbonyl group of reducing sugars with a free amino group of DNA, proteins and LDL macromolecules. The reaction proceeds by nucleophilic addition reaction followed by dehydration, cyclization and rearrangement to form AGEs. The role of glucose in the glycation of proteins has been widely studied however the role of other reducing monosaccharides such as D-ribose in glycation and their resulting effects on animal model has received much less attention. AGEs are heterogeneous class of compounds containing a mixture of cyclic and open chain structures out of which large numbers of AGEs are not determined till date. However, few AGEs which are known like pentosidine, carboxymethyl-lysine, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19689277 carboxyethyl-lysine, fructosyl-lysine, which plays an important role in atherosclerosis and nephropathy. The lipoprotein glycation process occurs both on the apoprotein B and on phospholipid components of LDL. It leads both functional alterations in LDL clearance and increased susceptibility to oxidative modifications. In addition, oxidative stress and other conditions causing oxidation of LDL stimulate the synthesis of nuclear polymers of adenosine diphosphate ribose, which in turn can release monomeric ADP-ribose. The bioavailability of D-ribose makes this carbonyl species quite reactive and damaging, therefore having direct implication in diabetes. There are ample evidences which indicate the role of lipoprotein glycation in the inflammatory reactions in the vessel wall. Various oxidative stresses of different proteins may be involved in proinflammatory immune mechanisms. These may involve innate immune signals, Toll-like receptors and adaptive immunity signals which are both cell-mediated and antibodymediated. There are ample of evidences supporting the pathogenic role of humoral response to modified lipoproteins. This is mainly due to the fact that modified LDL and its corresponding antibodies form modified LDL immune complexes, which are able to activate phagocytic PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19692133 cells through engagement of Fc receptors. Engagement of Fc receptors by mLDL-IC is particularly significant because it delivers stronger activating signals to phagocytic cells than the engagement of scavenger receptors by modified LDL. Native LDL was found to be moderately immunogenic in experimental animals, while, modified form of LDL was found to be highly immunogenic. This study was aimed to see the immunogenicity of native and glycated LDL. The cross reactivity experiments were performed to check the specificity of the purchase LY3039478 raised antibodies using various glycated Immunogenicity of LDL and non-glycated inhibitors including poly amino acids. Moreover, the immuno-histochemistry was performed to see the immune complex deposition in the kidney of immunized female rabbits. Measurement of hydroxyl radical Detection of hydroxyl radicals was carried out by measuring thiobarbituric acid reactive 2-deoxy-D-ribose oxidation products. Reaction mixtures containing 80 mM D-ribose, and LDL was incubated at 37uC for two weeks. The degradation of 2-deoxy-D-ribose was measured by adding l mL of 2.8% trichloroacetic acid, 1 mL of 1% thiobarbituric acid followed by heating at 100uC for 10 min. After cooling the absorbance was read at 532 nm. Materials and Methods Ethics statement The immunization work was approved by Institutional Animal Ethical Committee of Integral University, Lucknow, India by approval No: IU/Biotech/Project/CPCSEA/12

Share this post on:

Author: GTPase atpase